A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Multiple states have reached a tentative new agreement with the Sackler family, who made billions of dollars marketing OxyContin, the drug that set off the U.S. opioid crisis. New York State Attorney ...

Opioid abuse tells a tragic American story since avoidable deaths began in the 1990s. Nearly 700,000 people lost their lives to overdoses of OxyContin and offshoots of the highly addictive ...

Following efforts made by Florida’s Attorney’s General Office, as well as other states, a $7.4 billion multistate settlement has been reached with members of the Sackler family and Purdue Pharma, ...

Last week, members of the Sackler family, which owns the pharmaceutical company known for selling OxyContin, agreed to a $7.4 ...